USFDA makes 'certain' observations for Torrent Pharma's Indrad plant

The audit at Indrad plant of the company was carried out by the United
States Food and Drug Administration (USFDA) in April.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-makes-certain-observations-for-torrent-pharmas-indrad-plant/articleshow/69053644.cms

Comments

Popular posts from this blog

Freshers Job: Life Sciences Associate – Claims Vacancy at Genpact

Piramal Pharma Program Associate Vacancy Available